These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17140756)

  • 1. Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: a putative marker of an ongoing inflammatory process.
    McRae A; Martins RN; Fonte J; Kraftsik R; Hirt L; Miklossy J
    Exp Gerontol; 2007 Apr; 42(4):355-63. PubMed ID: 17140756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease.
    Lindberg C; Chromek M; Ahrengart L; Brauner A; Schultzberg M; Garlind A
    Neurochem Int; 2005 Jun; 46(7):551-7. PubMed ID: 15843049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.
    Freund-Levi Y; Hjorth E; Lindberg C; Cederholm T; Faxen-Irving G; Vedin I; Palmblad J; Wahlund LO; Schultzberg M; Basun H; Eriksdotter Jönhagen M
    Dement Geriatr Cogn Disord; 2009; 27(5):481-90. PubMed ID: 19439966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's disease.
    Taniguchi M; Okayama Y; Hashimoto Y; Kitaura M; Jimbo D; Wakutani Y; Wada-Isoe K; Nakashima K; Akatsu H; Furukawa K; Arai H; Urakami K
    Dement Geriatr Cogn Disord; 2008; 26(2):117-22. PubMed ID: 18654083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: preliminary studies.
    McIntyre JA; Chapman J; Shavit E; Hamilton RL; Dekosky ST
    Autoimmunity; 2007 Jul; 40(5):390-6. PubMed ID: 17612901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is pigment epithelium-derived factor level in cerebrospinal fluid a promising biomarker for early diagnosis of Alzheimer's disease?
    Yamagishi S; Inagaki Y; Takeuchi M; Sasaki N
    Med Hypotheses; 2004; 63(1):115-7. PubMed ID: 15193361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis and Alzheimer's disease.
    Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
    Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological markers in cerebrospinal fluid (CSF) and evaluation of in vitro effect of CSF on PC12 cell line viability in Alzheimer's disease.
    Yaka E; Egrilmez MY; Keskinoglu P; Cavdar Z; Genc S; Genc K; Iyilikci L; Yener GG
    Cell Biochem Funct; 2009 Aug; 27(6):395-401. PubMed ID: 19639578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease--a spirochetosis?
    Miklossy J
    Neuroreport; 1993 Jul; 4(7):841-8. PubMed ID: 8369471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.
    Schoonenboom NS; van der Flier WM; Blankenstein MA; Bouwman FH; Van Kamp GJ; Barkhof F; Scheltens P
    Neurobiol Aging; 2008 May; 29(5):669-75. PubMed ID: 17208336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
    Höglund K; Hansson O; Buchhave P; Zetterberg H; Lewczuk P; Londos E; Blennow K; Minthon L; Wiltfang J
    Neurodegener Dis; 2008; 5(5):268-76. PubMed ID: 18309230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
    Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K
    Dement Geriatr Cogn Disord; 2007; 23(5):316-20. PubMed ID: 17374949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.
    Montine TJ; Markesbery WR; Morrow JD; Roberts LJ
    Ann Neurol; 1998 Sep; 44(3):410-3. PubMed ID: 9749613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's disease.
    Maruyama M; Higuchi M; Takaki Y; Matsuba Y; Tanji H; Nemoto M; Tomita N; Matsui T; Iwata N; Mizukami H; Muramatsu S; Ozawa K; Saido TC; Arai H; Sasaki H
    Ann Neurol; 2005 Jun; 57(6):832-42. PubMed ID: 15929037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes of auto-antibodies against A beta 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients.
    Henkel AW; Dittrich PS; Groemer TW; Lemke EA; Klingauf J; Klafki HW; Lewczuk P; Esselmann H; Schwille P; Kornhuber J; Wiltfang J
    Mol Psychiatry; 2007 Jun; 12(6):601-10. PubMed ID: 17279093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
    Zetterberg H; Andreasson U; Hansson O; Wu G; Sankaranarayanan S; Andersson ME; Buchhave P; Londos E; Umek RM; Minthon L; Simon AJ; Blennow K
    Arch Neurol; 2008 Aug; 65(8):1102-7. PubMed ID: 18695061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
    Palumbo B; Siepi D; Sabalich I; Tranfaglia C; Parnetti L
    Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
    Hansson O; Buchhave P; Zetterberg H; Blennow K; Minthon L; Warkentin S
    Neurobiol Aging; 2009 Feb; 30(2):165-73. PubMed ID: 17646035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid and serum antimicroglial antibodies: prospects for early diagnosis of Alzheimer's disease.
    McRae A; Ling EA
    Expert Rev Neurother; 2003 Mar; 3(2):247-57. PubMed ID: 19810841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.